Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03246009 | Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients | completed | Phase 1 | 24 | Tianjin SinoBiotech Ltd.INDUSTRY | 1 | Aug 11, 2017 | clinicaltrials |
| NCT00594477 | Intensity Modulated Radiotherapy for Breast Cancer(IMRT) | completed | Phase 1 | 100 | Washington University School of MedicineOTHER | 1 | Aug 10, 2017 | clinicaltrials |
| NCT01104259 | Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer | completed | Phase 1 | 50 | University of WashingtonOTHER | 1 | Aug 10, 2017 | clinicaltrials |
| NCT01425476 | Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors | completed | Phase 1 / Phase 2 | 45 | Hartford HospitalOTHER | 1 | Aug 9, 2017 | clinicaltrials |
| NCT00788112 | Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast | completed | Phase 1 | 17 | University of California, San FranciscoOTHER | 1 | Aug 7, 2017 | clinicaltrials |
| NCT00764036 | Study of Artesunate in Metastatic Breast Cancer(ARTIC-M33/2) | completed | Phase 1 | 23 | Heidelberg UniversityOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT00331552 | Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer | completed | Phase 1 / Phase 2 | 30 | University of WashingtonOTHER | 1 | Jul 26, 2017 | clinicaltrials |
| NCT01105312 | Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 28 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jun 27, 2017 | clinicaltrials |
| NCT00637897 | Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast Cancer | completed | Phase 1 | 24 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00791037 | Vaccine Therapy in Treating Patients With Stage IV Breast Cancer | completed | Phase 1 / Phase 2 | 23 | University of WashingtonOTHER | 1 | May 25, 2017 | clinicaltrials |
| NCT01816035 | Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery | completed | Phase 1 | 13 | University of WashingtonOTHER | 1 | May 23, 2017 | clinicaltrials |
| NCT00004095 | Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 38 | Northwestern UniversityOTHER | 1 | Apr 18, 2017 | clinicaltrials |
| NCT00977275 | Treatment of T1N0 Invasive Breast Carcinoma by Local Excision Implant | completed | Phase 1 / Phase 2 | 45 | Massachusetts General HospitalOTHER | 1 | Apr 11, 2017 | clinicaltrials |
| NCT00934856 | A Study of Trastuzumab Emtansine (T-DM1) in Combination With Docetaxel, and Potentially Pertuzumab, in Participants With Advanced Breast Cancer | completed | Phase 1 / Phase 2 | 98 | Hoffmann-La RocheINDUSTRY | 4 | Apr 6, 2017 | clinicaltrials |
| NCT02391194 | Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery | completed | Phase 1 | 27 | Avelas Biosciences, Inc.INDUSTRY | 1 | Mar 22, 2017 | clinicaltrials |
| NCT00379509 | Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 | 20 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 21, 2017 | clinicaltrials |
| NCT01390818 | Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 146 | EMD SeronoINDUSTRY | 3 | Mar 7, 2017 | clinicaltrials |
| NCT00719875 | HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer | completed | Phase 1 | 24 | Yale UniversityOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT00086957 | Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 31 | City of Hope Medical CenterOTHER | 1 | Feb 27, 2017 | clinicaltrials |
| NCT00828074 | Sorafenib and Vinorelbine in Treating Women With Stage IV Breast Cancer | completed | Phase 1 / Phase 2 | 46 | City of Hope Medical CenterOTHER | 1 | Feb 27, 2017 | clinicaltrials |
| NCT00003761 | Vaccine Therapy in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 15, 2017 | clinicaltrials |
| NCT02583568 | Fluorescence Guided Surgery in Breast Cancer(MARGIN) | completed | Phase 1 / Phase 2 | 26 | University Medical Center GroningenOTHER | 1 | Feb 13, 2017 | clinicaltrials |
| NCT00826085 | Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall(DIGNITY) | completed | Phase 1 / Phase 2 | 17 | ImunonINDUSTRY | 1 | Jan 30, 2017 | clinicaltrials |
| NCT00755885 | Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 77 | Cancer Research UKOTHER | 1 | Jan 26, 2017 | clinicaltrials |
| NCT01339442 | BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer | completed | Phase 1 | 31 | Washington University School of MedicineOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT00005886 | Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer | completed | Phase 1 | — | University of Kansas Medical CenterOTHER | 1 | Jan 13, 2017 | clinicaltrials |
| NCT00849459 | Gene Therapy in Treating Women With Metastatic Breast Cancer | completed | Phase 1 | 3 | Max SungOTHER | 1 | Jan 11, 2017 | clinicaltrials |
| NCT00068263 | 3-Dimensional Conformal Radiation Therapy In Treating Women With Stage I or Stage II Breast Cancer Previously Treated With Lumpectomy and Axillary Node Dissection | completed | Phase 1 / Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 1 | Jan 4, 2017 | clinicaltrials |
| NCT00070057 | Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Dec 29, 2016 | clinicaltrials |
| NCT00637481 | A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer | completed | Phase 1 | 66 | National Cancer Institute (NCI)NIH | 1 | Dec 29, 2016 | clinicaltrials |
| NCT00800436 | A Dose-Finding Study of Subcutaneous Herceptin (Trastuzumab) in Healthy Male Volunteers and Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Females | completed | Phase 1 | 66 | Hoffmann-La RocheINDUSTRY | 2 | Dec 16, 2016 | clinicaltrials |
| NCT01372644 | Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial | completed | Phase 1 | 15 | NYU Langone HealthOTHER | 1 | Dec 5, 2016 | clinicaltrials |
| NCT00882674 | A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer | completed | Phase 1 | 8 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01172223 | Primary Chemotherapy in Patients With HER2-positive Early Breast Cancer(LAPADO) | completed | Phase 1 / Phase 2 | 81 | Prof Dirk EllingOTHER | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01254526 | Study of the Safety and Pharmacology of GDC-0980 in Combination With Paclitaxel With or Without Bevacizumab in Patients With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 1 | 52 | Genentech, Inc.INDUSTRY | 2 | Nov 2, 2016 | clinicaltrials |
| NCT01493336 | A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid Tumours | completed | Phase 1 | 37 | Hoffmann-La RocheINDUSTRY | 3 | Nov 2, 2016 | clinicaltrials |
| NCT01513083 | A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function | completed | Phase 1 | 28 | Hoffmann-La RocheINDUSTRY | 5 | Nov 2, 2016 | clinicaltrials |
| NCT02621957 | Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential | completed | Phase 1 | 15 | Genentech, Inc.INDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT00458237 | Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 11 | Beth Israel Deaconess Medical CenterOTHER | 1 | Oct 20, 2016 | clinicaltrials |
| NCT01432886 | A Study of Eribulin Mesylate With Trastuzumab for Advanced or Recurrent Human Epidermal Growth Factor Receptor 2-Positive (HER2+) Breast Cancer | completed | Phase 1 | 12 | Eisai Co., Ltd.INDUSTRY | 1 | Oct 7, 2016 | clinicaltrials |
| NCT01522820 | Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors | completed | Phase 1 | 18 | Roswell Park Cancer InstituteOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT00573495 | Multipeptide Vaccine for Advanced Breast Cancer | completed | Phase 1 | 11 | University of PennsylvaniaOTHER | 1 | Sep 29, 2016 | clinicaltrials |
| NCT02033551 | A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors | completed | Phase 1 | 47 | AbbVieINDUSTRY | 3 | Sep 27, 2016 | clinicaltrials |
| NCT00691379 | Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer | completed | Phase 1 / Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT01640665 | Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors | completed | Phase 1 | 24 | Yale UniversityOTHER | 1 | Sep 16, 2016 | clinicaltrials |
| NCT01451632 | A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers | completed | Phase 1 | 48 | Merrimack PharmaceuticalsINDUSTRY | 1 | Sep 8, 2016 | clinicaltrials |
| NCT00887575 | Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer | completed | Phase 1 / Phase 2 | 54 | SCRI Development Innovations, LLCOTHER | 1 | Sep 7, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Aug 11, 2017source: clinicaltrials